HIV molecular immunology database

 

Patient Detail

Patient Code 402I03
Patient Sex Male
Risk Factor Sex with male (SM)
Infection Country US
Infection City
Infection Year
HLA Type A3, A33, B15, B27
Patient Ethnicity White
Progression
Species human
Patient Note Subject 402I03, 32 years old, who participated in a vaccine trial, acquired HIV within 577 days of administration of vCP65/gp120 5 times. Viral load was at2,109 copies/ml 242d post-infection (dpi). Response to epitopes Gag IRLRPGGKK, Gag KRWIILGLNK, Gag MMQRGNFRNQRKIVK, Gag GLNKIVRMY, Env SFNCGGEFF and Env LQRAGRAILHIPTRI by EliSpot was 3,960, 5,310, 570, 2,510, 750 and 190 SFC/106 PBMC, after HIV-1 infection. [Horton2006a, PMID: 16973582].
CTL CD8+ Records 54934, 54948, 54949, 54950, 54951, 54952
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health